Gastroenteritis

Gastroenteritis is a common disease of the gut that can be highly infectious and make you feel sick very quickly. It is triggered when the digestive system becomes infected and inflamed, causing abdominal cramps, diarrhoea and vomiting with severity ranging from a mild tummy upset to severe and life-threatening dehydration.

Gastroenteritis is a major burden in developing countries and can be fatal for infants, older adults and people with compromised immune systems. Diarrhoeal disease is the second leading cause of death in children under five and kills around 525,000 children globally every year.

Causes of gastroenteritis

Risk factors

Types of gastroenteritis

Symptoms of gastroenteritis

Treating gastroenteritis

Prevention of gastroenteritis

Our gastroenteritis research

As antimicrobial resistance becomes more widespread and current treatment measures become less effective, the development of new therapeutics and vaccines for gastroenteritis is more important than ever.

Despite medical advances, gastroenteritis still kills many children and elderly people each year, particularly in developing countries. Our researchers are working on better vaccines and therapeutics to prevent severe gastroenteritis and save lives. This includes research to harness the protective properties of the human microbiome.

Hudson Institute researchers are using specialist preclinical infection models and genetic screens to lay the groundwork for improved drug efficacy and to understand the infection mechanisms of a diverse range of bacteria and viruses that cause life threatening disease. This work has the potential to rapidly advance the treatment of gastroenteritis and the prevention of serious illness or death.  

Understanding the infection biology of E. coli and Shigella

Professor Elizabeth Hartland , Director and CEO of Hudson Institute of Medical Research

Epithelial cells lining the intestine form a barrier to the external environment and are regularly exposed to a complex microbiological ecosystem comprising the microbiota and pathogens. During infection, bacterial pathogens such as Escherichia coli and Shigella damage the epithelial barrier and activate host inflammatory signalling and cell death responses, thereby interfering with epithelial homeostasis. Tissue resident epithelial stem cells maintain epithelial homeostasis and mediate epithelial regeneration. However, how infection affects epithelial repair and regeneration is poorly understood.

We are utilising human intestinal organoid models to study epithelial responses and regeneration and examining the role of innate immune factors in gut repair following bacterial infection.

Team | Professor Elizabeth Hartland AM, Dr Cristina Giogha, Dr Eva Chan

Understanding the role of a toxin in Campylobacter gastroenteritis

Diarrhoea-causing bacteria adapted to spread in hospitals

Gastroenteritis collaborators

Share this page